News
GSK, RSV and EMA
Digest more
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
Abrysvo has also been approved as a maternal vaccine to prevent RSV in newborns, an indication that GSK abandoned for Arexvy, but in that category it has to compete with Sanofi and AstraZeneca’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback